Safety study of SYH9017 for overweight and obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old and overweight or have obesity (based on BMI).
- Your weight has not changed much (less than 5%) in the last 3 months.
- You are not using any weight-loss medications, antidepressants, or other drugs that could affect your weight.
- You do not have diabetes, thyroid problems, or a personal or family history of medullary thyroid cancer.
- You are willing to use effective non-hormonal birth control (and not plan to donate sperm/eggs) for 6 months after the study ends.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injected medicine called SYH2092 in healthy adults. It aims to see how safe it is and how the body handles it, which could help develop a future treatment for conditions like diabetes or obesity.
This study tests a new injection called SYH2082 in healthy volunteers to see how the body handles it and what side effects might occur. It is an early-stage trial that may help in developing a treatment for weight-related conditions.
This study tests a new medication called HS-20094 for people who are overweight or have obesity. It is designed to help with weight loss and will last for several months to see how safe and effective the medicine is.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
This study tests an investigational injection called SYH2069 for weight loss in people who are obese but do not have diabetes. It aims to see if the drug is safe and helps reduce body weight.
This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.